BIOCHEMICAL ACTION AND SNARE COMPLEX CLEAVAGE IN THE COMBINED TREATMENT OF MASSETER HYPERTROPHY AND BRUXISM WITH BOTULINUM TOXIN
DOI:
https://doi.org/10.51891/rease.v12i11.32978Keywords:
Botulinum toxins, Type A. Bruxism, Masseter muscleAbstract
Objective: to analyze the relationship between the biochemical action of botulinum toxin type A on the SNARE complex and its effects on the concomitant management of masseter hypertrophy and bruxism. Methods: a narrative review based on targeted searches of PubMed records, full texts available in PubMed Central, and original journal publications, conducted in November 2026. Relevant mechanistic studies, consensus reports, and clinical investigations were selected. Results: selective cleavage of SNAP-25 impairs acetylcholine exocytosis and temporarily reduces muscle activation. Clinical trials support reductions in masseter prominence, whereas effects on bruxism episode frequency and pain are heterogeneous. Reduced contraction intensity alone does not demonstrate modification of the mechanisms generating the behavior. Combining treatment with an occlusal splint provided no additional benefit for muscle thickness in one specific trial. Functional changes and uncertainties regarding repeated exposure require individualized assessment. Conclusion: molecular plausibility supports peripheral control of muscle activity but does not establish a cure for bruxism. Treatment planning should distinguish morphological, functional, and symptomatic goals.
Downloads
Downloads
Published
Issue
Section
Categories
License
Atribuição CC BY